Skip to main content
AAN.com

Abstract

Background: There is almost no longitudinal information about measured cognitive performance during the menopause transition (MT).
Methods: We studied 2,362 participants from the Study of Women's Health Across the Nation for 4 years. Major exposures were time spent in MT stages, hormone use prior to the final menstrual period, and postmenopausal current hormone use. Outcomes were longitudinal performance in three domains: processing speed (Symbol Digit Modalities Test [SDMT]), verbal memory (East Boston Memory Test [EBMT]), and working memory (Digit Span Backward).
Results: Premenopausal, early perimenopausal, and postmenopausal women scored higher with repeated SDMT administration (p ≤ 0.0008), but scores of late perimenopausal women did not improve over time (p = 0.2). EBMT delayed recall scores climbed during premenopause and postmenopause (p ≤ 0.01), but did not increase during early or late perimenopause (p ≥ 0.14). Initial SDMT, EBMT-immediate, and EBMT-delayed tests were 4%–6% higher among prior hormone users (p ≤ 0.001). On the SDMT and EBMT, compared to the premenopausal referent, postmenopausal current hormone users demonstrated poorer cognitive performance (p ≤ 0.05) but performance of postmenopausal nonhormone users was indistinguishable from that of premenopausal women.
Conclusions: Consistent with transitioning women's perceived memory difficulties, perimenopause was associated with a decrement in cognitive performance, characterized by women not being able to learn as well as they had during premenopause. Improvement rebounded to premenopausal levels in postmenopause, suggesting that menopause transition–related cognitive difficulties may be time-limited. Hormone initiation prior to the final menstrual period had a beneficial effect whereas initiation after the final menstrual period had a detrimental effect on cognitive performance.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (appendix_e-1.doc)
File (appendix_e-2.doc)
File (appendix_e-3.doc)

REFERENCES

1.
Mitchell E, Woods N. Midlife women's attributions about perceived memory changes: observations from the Seattle Midlife Women's Health Study. J Womens Health Gend Based Med 2001;10:351–362.
2.
Luetters CM, Seeman TE, Huang MH, et al. Menopause transition stage and endogenous estradiol and follicle stimulating hormone levels are not related to cognitive performance: cross-sectional results from the Study of Women's Health Across the Nation (SWAN). J Womens Health 2007;16:331–344.
3.
Morrison JH, Brinton RD, Schmidt PJ, Gore AC. Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women. J Neurosci 2006;26:10332–10348.
4.
Fuh JL, Wang SJ, Lee SJ, Lu SR, Juang KD. A longitudinal study of cognition change during early menopausal transition in a rural community. Maturitas 2006;53:447–453.
5.
Meyer PM, Powell LH, Wilson RS, et al. A population-based longitudinal study of cognitive functioning in the menopausal transition. Neurology 2003;61:801–806.
6.
McEwen BS. Invited review: estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol 2001;91:2785–2801.
7.
McEwen B. Estrogen actions throughout the brain. Recent Prog in Horm Res 2002;7:357–384.
8.
Sowers MF, Crawford SL, Sternfeld B, et al. SWAN: a multicenter, multiethnic, community-based cohort study of women and the menopausal transition. In: Lobo RA, Kelsey J, Marcus R, eds. Menopause Biology and Pathobiology. San Diego, CA: Academic Press;
9.
Smith A. Symbol Digit Modalities Test. Los Angeles, CA; Western Psychological Service;
10.
Albert M, Smith LA, Scherr PA, Taylor JO, Evans DA, Funkenstein HH. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci 1991;57:167–178.
11.
Wechsler D. A standardized memory scale for clinical use. Psychology 1945;19:87–95.
12.
Jonides J, Smith EE, Marchuetz C, Koeppe RA, Reuter-Lorenz PA. Inhibition in verbal working memory revealed by brain activation. Proc Natl Acad Sci USA 1998;95:8410–8413.
13.
Psychological Corporation. WAIS-III and WMS-III: Technical manual. San Antonio, TX: Psychological Corporation/Harcourt Brace;
14.
Matthews KA, Kiefe CI, Lewis CE, Liu K, Sidney S, Yunis C. Socioeconomic trajectories and incident hypertension in a biracial cohort of young adults. Hypertension 2002;39:772–776.
15.
Gerstorf D, Herlitz A, Smith J. Stability of sex difference in cognition in advanced old age: The role of education and attrition. J Gerontol B Psychol Sci Soc Sci 2006;61:245–249.
16.
Stata Manual: [U] 23.11: Obtaining Robust Variance Estimates. 254–258.
17.
White H. A heteroscedasticity-consistent covariance matrix estimator and direct test for heteroscedasticity. Econometrica 1980;38:817–838.
18.
Lamar M, Resnick SM, Zonderman AB. Longitudinal changes in verbal memory in older adults: Distinguishing the effects of age from repeat testing. Neurology 2003:60:82–86.
19.
Brinton RD. The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature? J Neuroendocrinol 2007;19:77–81.
20.
Brinton RD. Investigative models for determining hormone therapy-induced outcomes in Brain: Evidence in support of a healthy cell bias of estrogen action. Ann NY Acad Sci 2005;1052:57–74.
21.
Maki PM. Menopause and cognition. In: Lobo RA, ed. Treatment of the Postmenopausal Woman: Basic and Clinical Aspects.
22.
Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465–1477.
23.
Manson JE, Allison MA, Rossouw JE. Estrogen therapy and coronary artery calcification. N Engl J Med 2007;356:2591–2602.
24.
Siegfried T. Neuroscience: it's all in the timing. Nature 2007;445:359–361.
25.
Mendelsohn ME, Karas RH. HRT and the young at heart. N Engl J Med 2007;356:2639–2641.
26.
Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health 2006;96:1226–1235.
27.
Verhaeghen P, Salthouse TA. Meta-analysis of age-cognition relations in adulthood: estimates of linear and non-linear effects and structural models. Psychol Bull 1997;122:231–249.
28.
Lachman ME, Tun PA. Cognitive testing in large-scale surveys: assessment by telephone. In: Hofer S, Alwin D, eds. Handbook on Cognitive Aging: Interdisciplinary Perspectives. Thousand Oaks, CA: Sage Publishers;
29.
Lachman ME, Neupert SD, Bertrand R, Jette AM. The effects of strength training on memory in older adults. J Aging Phys Act 2006;14:59–73.

Information & Authors

Information

Published In

Neurology®
Volume 72Number 21May 26, 2009
Pages: 1850-1857
PubMed: 19470968

Publication History

Published online: May 26, 2009
Published in print: May 26, 2009

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

G. A. Greendale, MD
From the Division of Geriatrics, David Geffen School of Medicine (G.A.G., M.-H.H., T.S., A.S.K.), and Department of Community Health Sciences, School of Public Health (R.G.W.), University of California, Los Angeles; Irvine School of Medicine (C.L.), University of California, Irvine; Division of Public Health Sciences (N.E.A.), Wake Forest University School of Medicine, Winston-Salem, NC; and Alaska Native Epidemiology Center (J.J.), Alaska Native Tribal Health Consortium, Anchorage.
M-H Huang, DrPh
From the Division of Geriatrics, David Geffen School of Medicine (G.A.G., M.-H.H., T.S., A.S.K.), and Department of Community Health Sciences, School of Public Health (R.G.W.), University of California, Los Angeles; Irvine School of Medicine (C.L.), University of California, Irvine; Division of Public Health Sciences (N.E.A.), Wake Forest University School of Medicine, Winston-Salem, NC; and Alaska Native Epidemiology Center (J.J.), Alaska Native Tribal Health Consortium, Anchorage.
R. G. Wight, PhD
From the Division of Geriatrics, David Geffen School of Medicine (G.A.G., M.-H.H., T.S., A.S.K.), and Department of Community Health Sciences, School of Public Health (R.G.W.), University of California, Los Angeles; Irvine School of Medicine (C.L.), University of California, Irvine; Division of Public Health Sciences (N.E.A.), Wake Forest University School of Medicine, Winston-Salem, NC; and Alaska Native Epidemiology Center (J.J.), Alaska Native Tribal Health Consortium, Anchorage.
T. Seeman, PhD
From the Division of Geriatrics, David Geffen School of Medicine (G.A.G., M.-H.H., T.S., A.S.K.), and Department of Community Health Sciences, School of Public Health (R.G.W.), University of California, Los Angeles; Irvine School of Medicine (C.L.), University of California, Irvine; Division of Public Health Sciences (N.E.A.), Wake Forest University School of Medicine, Winston-Salem, NC; and Alaska Native Epidemiology Center (J.J.), Alaska Native Tribal Health Consortium, Anchorage.
C. Luetters, MS
From the Division of Geriatrics, David Geffen School of Medicine (G.A.G., M.-H.H., T.S., A.S.K.), and Department of Community Health Sciences, School of Public Health (R.G.W.), University of California, Los Angeles; Irvine School of Medicine (C.L.), University of California, Irvine; Division of Public Health Sciences (N.E.A.), Wake Forest University School of Medicine, Winston-Salem, NC; and Alaska Native Epidemiology Center (J.J.), Alaska Native Tribal Health Consortium, Anchorage.
N. E. Avis, PhD
From the Division of Geriatrics, David Geffen School of Medicine (G.A.G., M.-H.H., T.S., A.S.K.), and Department of Community Health Sciences, School of Public Health (R.G.W.), University of California, Los Angeles; Irvine School of Medicine (C.L.), University of California, Irvine; Division of Public Health Sciences (N.E.A.), Wake Forest University School of Medicine, Winston-Salem, NC; and Alaska Native Epidemiology Center (J.J.), Alaska Native Tribal Health Consortium, Anchorage.
J. Johnston, PhD
From the Division of Geriatrics, David Geffen School of Medicine (G.A.G., M.-H.H., T.S., A.S.K.), and Department of Community Health Sciences, School of Public Health (R.G.W.), University of California, Los Angeles; Irvine School of Medicine (C.L.), University of California, Irvine; Division of Public Health Sciences (N.E.A.), Wake Forest University School of Medicine, Winston-Salem, NC; and Alaska Native Epidemiology Center (J.J.), Alaska Native Tribal Health Consortium, Anchorage.
A. S. Karlamangla, PhD, MD
From the Division of Geriatrics, David Geffen School of Medicine (G.A.G., M.-H.H., T.S., A.S.K.), and Department of Community Health Sciences, School of Public Health (R.G.W.), University of California, Los Angeles; Irvine School of Medicine (C.L.), University of California, Irvine; Division of Public Health Sciences (N.E.A.), Wake Forest University School of Medicine, Winston-Salem, NC; and Alaska Native Epidemiology Center (J.J.), Alaska Native Tribal Health Consortium, Anchorage.

Notes

Address correspondence and reprint requests to Dr. Gail A. Greendale, Division of Geriatrics, David Geffen School of Medicine at UCLA, 10945 Le Conte Avenue, Suite 2339, Los Angeles, CA 90095-1687 [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Association Between Serum Follicle-Stimulating Hormone Levels and Cognitive Function in Middle-Aged and Older Women, Journal of Korean Medical Science, 40, (2025).https://doi.org/10.3346/jkms.2025.40.e15
    Crossref
  2. Brain health and episodic memory function at midlife: Exploring the effects of sex differences and menopause status, Encyclopedia of the Human Brain, (95-112), (2025).https://doi.org/10.1016/B978-0-12-820480-1.00179-0
    Crossref
  3. Sex differences in risk/reward decision making, Encyclopedia of the Human Brain, (706-725), (2025).https://doi.org/10.1016/B978-0-12-820480-1.00110-8
    Crossref
  4. Counseling in menopausal women: How to address the benefits and risks of menopause hormone therapy. A FIGO position paper, South African General Practitioner, 5, 1, (14-28), (2024).https://doi.org/10.36303/SAGP.0397
    Crossref
  5. Systematic review and meta-analysis of the effects of menopause hormone therapy on cognition, Frontiers in Endocrinology, 15, (2024).https://doi.org/10.3389/fendo.2024.1350318
    Crossref
  6. Acute Aromatase Inhibition Impairs Neural and Behavioral Auditory Scene Analysis in Zebra Finches, eneuro, 11, 3, (ENEURO.0423-23.2024), (2024).https://doi.org/10.1523/ENEURO.0423-23.2024
    Crossref
  7. Long-term cognitive effects of menopausal hormone therapy: Findings from the KEEPS Continuation Study, PLOS Medicine, 21, 11, (e1004435), (2024).https://doi.org/10.1371/journal.pmed.1004435
    Crossref
  8. Higher FSH Level Is Associated With Increased Risk of Incident Hip Fracture in Older Adults, Independent of Sex Hormones, The Journal of Clinical Endocrinology & Metabolism, (2024).https://doi.org/10.1210/clinem/dgae690
    Crossref
  9. Endogenous Estrogens and Brain Activation During Verbal Memory Encoding and Recognition in the Postmenopause, The Journal of Clinical Endocrinology & Metabolism, (2024).https://doi.org/10.1210/clinem/dgae467
    Crossref
  10. Mapping global prevalence of menopausal symptoms among middle-aged women: a systematic review and meta-analysis, BMC Public Health, 24, 1, (2024).https://doi.org/10.1186/s12889-024-19280-5
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share